TRIM33 and dermatomyositis: The proportion of 180–360 bp cfDNA fragments varies significantly between the TWT and TOT subgroups, which may serve as an effective indicator of concomitant tumors in dermatomyositis patients with anti-TIF1g antibodies (Figure 2F).